257 related articles for article (PubMed ID: 10095896)
1. [Familial chronic mucocutaneous candidiasis associated with autoimmune polyendocrinopathy. Treatment with fluconazole: 3 cases].
Rybojad M; Abimelec P; Feuilhade M; Morel P; Bourrat E
Ann Dermatol Venereol; 1999 Jan; 126(1):54-6. PubMed ID: 10095896
[TBL] [Abstract][Full Text] [Related]
2. [Autoimmune polyendocrinopathy and chronic mucocutaneous candidiasis].
Proto G; Leoni S; Torossi I; Mazzolini A; Grimaldi F; Bertolissi F
Minerva Med; 1992; 83(7-8):475-8. PubMed ID: 1522973
[TBL] [Abstract][Full Text] [Related]
3. Dermatological manifestations of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy syndrome.
Collins SM; Dominguez M; Ilmarinen T; Costigan C; Irvine AD
Br J Dermatol; 2006 Jun; 154(6):1088-93. PubMed ID: 16704638
[TBL] [Abstract][Full Text] [Related]
4. Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasis.
Rautemaa R; Richardson M; Pfaller MA; Perheentupa J; Saxén H
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):182-5. PubMed ID: 18597968
[TBL] [Abstract][Full Text] [Related]
5. Autoimmune polyglandular syndrome (APS) type 1 and candida onychomycosis.
Manz B; Scholz GH; Willgerodt H; Haustein UF; Nenoff P
Eur J Dermatol; 2002; 12(3):283-6. PubMed ID: 11978574
[TBL] [Abstract][Full Text] [Related]
6. [One case of type 1 auto-immune polyendocrinopathy or APECED].
Puzenat E; Pepin L; Bertrand AM; Pelletier F; Monnier D; Levang J; Mermet I; Humbert P; Aubin F
Ann Dermatol Venereol; 2010 Dec; 137(12):794-8. PubMed ID: 21134582
[TBL] [Abstract][Full Text] [Related]
7. Autosomal dominant chronic mucocutaneous candidiasis and primary hypothyroidism complicated by oesophageal carcinoma.
Koch D; Lilic D; Carmichael AJ
Clin Exp Dermatol; 2009 Dec; 34(8):e818-20. PubMed ID: 19778308
[TBL] [Abstract][Full Text] [Related]
8. Terbinafine effectiveness in ketoconazole-resistant mucocutaneous candidasis in polyglandular autoimmune syndrome type 1.
Hassan G
J Assoc Physicians India; 2003 Mar; 51():323. PubMed ID: 12839367
[No Abstract] [Full Text] [Related]
9. Oral mucous squamous cell carcinoma-an anticipated consequence of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED).
Böckle BC; Wilhelm M; Müller H; Götsch C; Sepp NT
J Am Acad Dermatol; 2010 May; 62(5):864-8. PubMed ID: 20304522
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune polyendocrinopathy candidiasis ectodermal dystrophy: known and novel aspects of the syndrome.
Kisand K; Peterson P
Ann N Y Acad Sci; 2011 Dec; 1246():77-91. PubMed ID: 22236432
[TBL] [Abstract][Full Text] [Related]
11. [Diagnostic image (9). Chronic mucocutaneous candidiasis].
van der Meer JW; Weemaes CM
Ned Tijdschr Geneeskd; 2000 Oct; 144(44):2103. PubMed ID: 11103671
[TBL] [Abstract][Full Text] [Related]
12. Neurologic consequences of autoimmune polyglandular syndrome type 1.
Berger JR; Weaver A; Greenlee J
Neurology; 2008 Jun; 70(23):2248-51. PubMed ID: 18519874
[TBL] [Abstract][Full Text] [Related]
13. Impaired T(H)17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy.
Ng WF; von Delwig A; Carmichael AJ; Arkwright PD; Abinun M; Cant AJ; Jolles S; Lilic D
J Allergy Clin Immunol; 2010 Nov; 126(5):1006-15, 1015.e1-4. PubMed ID: 20934207
[TBL] [Abstract][Full Text] [Related]
14. Candidiasis endocrinopathy syndrome. Treatment with itraconazole.
DePadova-Elder SM; Ditre CM; Kantor GR; Koblenzer PJ
Arch Dermatol; 1994 Jan; 130(1):19-22. PubMed ID: 8285736
[No Abstract] [Full Text] [Related]
15. Chronic mucocutaneous candidosis associated with hypothyroidism: a distinct syndrome?
Coleman R; Hay RJ
Br J Dermatol; 1997 Jan; 136(1):24-9. PubMed ID: 9039290
[TBL] [Abstract][Full Text] [Related]
16. [APS I--a severe autoimmune disease with endocrine and non-endocrine symptoms].
Gustafsson J; Alimohammadi M; Ekwall O; Gebre-Medhin G; Halldin-Stenlid M; Hedstrand H; Landgren E; Nilsson T; Rorsman F; Sköldberg F; Winqvist O; Kämpe O
Lakartidningen; 2004 Jun; 101(24):2096-8, 2101-3. PubMed ID: 15282984
[TBL] [Abstract][Full Text] [Related]
17. Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) patients.
Rautemaa R; Richardson M; Pfaller M; Koukila-Kähkölä P; Perheentupa J; Saxén H
J Antimicrob Chemother; 2007 Oct; 60(4):889-92. PubMed ID: 17704513
[TBL] [Abstract][Full Text] [Related]
18. The autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy or autoimmune polyglandular syndrome type 1.
Lankisch TO; Jaeckel E; Strassburg CP
Semin Liver Dis; 2009 Aug; 29(3):307-14. PubMed ID: 19676003
[TBL] [Abstract][Full Text] [Related]
19. New host defense mechanisms against Candida species clarify the basis of clinical phenotypes.
Hanna S; Etzioni A
J Allergy Clin Immunol; 2011 Jun; 127(6):1433-7. PubMed ID: 21497889
[TBL] [Abstract][Full Text] [Related]
20. Chronic Mucocutaneous Candidiasis in Autoimmune Polyendocrine Syndrome Type 1.
Humbert L; Cornu M; Proust-Lemoine E; Bayry J; Wemeau JL; Vantyghem MC; Sendid B
Front Immunol; 2018; 9():2570. PubMed ID: 30510552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
